Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
China Botanic Pharmaceutical Inc. does not have significant operations. It intends to explore and identify business opportunities within the United States, including a potential acquisition of an operating entity through a reverse merger, asset purchase, or similar transaction. The company was formerly known as Renhuang Pharmaceuticals, Inc. and changed its name to China Botanic Pharmaceutical Inc. in November 2010. China Botanic Pharmaceutical Inc. was incorporated in 1988 and is based in New York, New York.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is overvalued on EV/EBITDA.
Buy
Sell